Operating income before deduction of amortization: viraxbiolabs.com (VRAX)
Virax Biolabs Group (VRAX) delegates the manufacturing of test systems to external contractors, focusing instead on marketing and R&D. EBITDA cash flow reflects operating revenue volatility, while the 0.00 value aligns with the current metric. The neutral geopolitical status of biomedicine ensures business stability. Management plans to scale the diagnostic network and expand into emerging regions to combat infections.
Virax Biolabs (VRAX) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Debt to Equity Virax Biolabs Group|VRAX - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Virax Biolabs Group Limited|VRAX - Company Debts|Debt to Net Assets Ratio Virax Biolabs|VRAX - Company Long-Term Debts|Company Short-Term Debts Virax Biolabs|Immediate Liquidity Ratio viraxbiolabs.com
- company profitability and valuation multiples indicators:
VRAX - Net Income|Expected Net Income Virax Biolabs Group|VRAX - P/E Multiple|Future Price to Earnings viraxbiolabs.com|VRAX - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Virax Biolabs|VRAX - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Virax Biolabs|VRAX - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months viraxbiolabs.com|VRAX - Earnings growth in current year|Earnings growth forecast for next year Virax Biolabs Group
- sales and revenue data:
Analysis of all company metrics:Virax Biolabs Corp
Virax Biolabs Group is establishing a sustainable cash flow driven by patent protection for its test systems and long-term government contracts in the biosafety sector. This indicator captures the actual volume of operating funds, stripped of accounting accruals, allowing investors to identify points of fundamental business undervaluation via current EBITDA based on the company's ability to generate physical liquidity.
Who Virax Biolabs Group competes with
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit before deduction of amortization SHC (Sotera Health Company)|Profit before payment of interest, taxes and amortization QDEL (quidel.com)|Operating profit EBITDA OPK (OPKO Health)|Operating income before deduction of amortization CareDx Corp (CDNA)|MRVI - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization FLGT (Fulgent)|LAB: Operating profit EBITDA|cytekbio.com (CTKB) - Operating profit EBITDA|Operating profit before deduction of amortization OSUR|Operating profit before amortization XGN (Exagen Diagnostics)|Operating profit before deduction of amortization MDXH (MDxHealth Inc.)|LUCD (Lucid Diagnostics, Inc) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA PRE (Prenetics)|Insight Molecular Diagnostics, Inc. - Profit before payment of interest, taxes and amortization|Trinity Biotech Corp - Operating profit EBITDA|Operating income before deduction of amortization ProPhase Labs Inc PRPH|Ainos Corp (AIMD) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization CoDx (CODX)|Profit before payment of interest, taxes and amortization Heart Test Laboratories|Profit before payment of interest, taxes and amortization BMRA|Operating profit EBITDA CDIO|Operating profit EBITDA Onconetix Inc (ONCO)|Operating profit EBITDA BJDX (Bluejay)|Aspira Women's Health Inc - Profit before payment of interest, taxes and amortization|AXDX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization Centogene CNTG|ENZ (enzo.com) - Operating profit before deduction of amortization|Fresh2 Group - Income before deduction of interest, taxes and amortization|GENE (Genetic Technologies Ltd) - Operating profit EBITDA|ME - Operating profit before depreciation charges|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
